Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $3.35 $5.09 Wednesday, 8th May 2024 RLMD stock ended at $3.83. This is 0.262% more than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 5.32% from a day low at $3.75 to a day high of $3.95.
90 days $3.35 $7.22
52 weeks $2.36 $7.22

Historical Relmada Therapeutics, Inc. prices

Date Open High Low Close Volume
Dec 13, 2023 $2.43 $2.52 $2.43 $2.50 101 662
Dec 12, 2023 $2.51 $2.55 $2.45 $2.45 148 608
Dec 11, 2023 $2.61 $2.61 $2.51 $2.51 159 399
Dec 08, 2023 $2.56 $2.57 $2.53 $2.56 94 534
Dec 07, 2023 $2.56 $2.59 $2.52 $2.56 88 326
Dec 06, 2023 $2.53 $2.59 $2.52 $2.55 141 144
Dec 05, 2023 $2.50 $2.51 $2.47 $2.50 65 906
Dec 04, 2023 $2.52 $2.52 $2.46 $2.51 126 488
Dec 01, 2023 $2.45 $2.54 $2.42 $2.51 163 724
Nov 30, 2023 $2.56 $2.70 $2.46 $2.47 233 985
Nov 29, 2023 $2.72 $2.80 $2.45 $2.51 225 729
Nov 28, 2023 $2.82 $2.93 $2.72 $2.74 139 624
Nov 27, 2023 $2.95 $2.95 $2.85 $2.85 74 073
Nov 24, 2023 $2.92 $2.96 $2.87 $2.90 27 230
Nov 22, 2023 $2.94 $3.02 $2.85 $2.85 90 547
Nov 21, 2023 $2.99 $3.03 $2.83 $2.94 127 366
Nov 20, 2023 $2.84 $3.04 $2.80 $2.95 104 133
Nov 17, 2023 $2.98 $2.98 $2.80 $2.80 103 128
Nov 16, 2023 $3.04 $3.06 $2.92 $2.95 83 447
Nov 15, 2023 $2.97 $3.20 $2.97 $3.03 84 086
Nov 14, 2023 $2.84 $3.04 $2.84 $2.95 60 194
Nov 13, 2023 $2.88 $2.93 $2.76 $2.82 112 423
Nov 10, 2023 $3.02 $3.03 $2.88 $2.90 77 000
Nov 09, 2023 $3.01 $3.09 $2.95 $2.99 130 703
Nov 08, 2023 $3.00 $3.06 $2.96 $3.00 262 985
Click to get the best stock tips daily for free!

About Relmada Therapeutics, Inc.

Relmada Therapeutics. Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that is in Phase 3 clinical trials for the adjunctive or monotherapy treatment of major depressive disorder ... RLMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT